Background/Aims: PreventS-MD technology is designed to transform stroke prevention by offering personalised risk assessments based on individual risk factors. It utilises the internationally acclaimed Stroke Riskometer as its algorithm engine - endorsed by the World Stroke Organisation and World Heart Federation. Initiated due to the limitations of existing strategies, PreventS-MD's primary aim is to enhance the prevention and management of stroke and other non-communicable diseases (NCDs) across diverse populations.
Methods: The technology has undergone usability studies with ongoing clinical studies in New Zealand and abroad. The algorithm underwent randomised controlled trials and has been evaluated for feasibility and satisfaction internationally by healthcare professionals from 27 countries using a system usability scale (SUS).
Results: Research confirms the high usability and effectiveness of the algorithm engine in clinical settings, with findings published in top-tier journals including Lancet and Nature. It has been translated into 24 languages, including Māori, broadening its reach to serve over 5 billion global users potentially. Clinicians report high satisfaction with the platform, and users consistently adhere to preventative recommendations. The app has been downloaded by more than 200,000 persons from 78 countries and continually evaluated for accuracy.
Conclusion: PrevetnS-MD is advancing towards global commercialisation by collaborating with major digital health technology partners. This clinical software holds significant promise for reducing healthcare costs and lessening the burden on healthcare systems by effectively reducing the incidence of stroke and other NCDs. Its wide use could foster social inclusion, reinforce SDG achievement, and facilitate bridging gaps in universal health coverage.